Opiate Receptors and Antagonists
From Bench to Clinic
Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology
| Author: | ISBN: | 9781597451970 | |
| Publisher: | Humana Press | Publication: | March 12, 2009 |
| Imprint: | Humana | Language: | English |
| Author: | |
| ISBN: | 9781597451970 |
| Publisher: | Humana Press |
| Publication: | March 12, 2009 |
| Imprint: | Humana |
| Language: | English |
Comprehensive and authoritative, Opioid Receptors and Antagonists: From Bench to Clinic offers neuroscientists, pharmacologists and interested clinicians a unique survey of the extensive and diverse research efforts currently employed with opioid antagonists to develop novel innovative drug therapies.
- Summarizes the present understanding of the chemistry, pharmacology and molecular biology of opioid receptors and their subtypes
- Highlights differences and similarities between the opioid pharmacology of animals and human
- Describes current and potential therapeutic areas for opioid antagonists, including substance abuse, alcohol and ingestive behaviors, behavioral disorders and other medical indications, supported by nonclinical and clinical evidence
- Focuses on the development of exciting and innovative drug delivery approaches that are being used with opioid antagonists for the above medical indications
Comprehensive and authoritative, Opioid Receptors and Antagonists: From Bench to Clinic offers neuroscientists, pharmacologists and interested clinicians a unique survey of the extensive and diverse research efforts currently employed with opioid antagonists to develop novel innovative drug therapies.
- Summarizes the present understanding of the chemistry, pharmacology and molecular biology of opioid receptors and their subtypes
- Highlights differences and similarities between the opioid pharmacology of animals and human
- Describes current and potential therapeutic areas for opioid antagonists, including substance abuse, alcohol and ingestive behaviors, behavioral disorders and other medical indications, supported by nonclinical and clinical evidence
- Focuses on the development of exciting and innovative drug delivery approaches that are being used with opioid antagonists for the above medical indications
